Luke M. Beshar - Jun 8, 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Director
Signature
/s/ Jesse Shefferman, Attorney-in-fact
Stock symbol
TARA
Transactions as of
Jun 8, 2022
Transactions value $
$0
Form type
4
Date filed
6/9/2022, 04:10 PM
Previous filing
Mar 16, 2022
Next filing
Jul 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +10K $0.00 10K Jun 8, 2022 Common Stock 10K $3.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.